scottpartnership.blogspot.com
The Scott Partnership: January 2013
http://scottpartnership.blogspot.com/2013_01_01_archive.html
Friday, 25 January 2013. Agency nurses – friend or foe? London, Friday 25 January 2013 –. Than not, agency healthcare professionals are the first in line for blame when overstretched hospitals experience complications and/or lowered levels of care. However, given the current healthcare situation, are we getting it wrong? HCL Nursing Managing Director Helen Rudanec has spoken out against recent articles in. 8220;As a business, we are constantly investing in our consultants and candidates to maintain the h...
scottpartnership.blogspot.com
The Scott Partnership: May 2013
http://scottpartnership.blogspot.com/2013_05_01_archive.html
Tuesday, 7 May 2013. Sciformix Corporation Celebrates Company’s Founding Day by Volunteering at Local Charities in India and Philippines. Helping the communities where we live and work by leveraging the extraordinary abilities of our people, ideas and resources. To find out more about the charities involved and a full schedule of activities for the Social Impact Initiative day please visit http:/ www.sciformix.com/about-us/corporate-responsibility. Email us at ask@sciformix.com. Posted by Tanu Arora.
scottpartnership.blogspot.com
The Scott Partnership: The Royal Mint Achieves New Level of Trade Effluent Monitoring with Analytical Technology Instrumentation
http://scottpartnership.blogspot.com/2013/03/the-royal-mint-achieves-new-level-of.html
Monday, 4 March 2013. The Royal Mint Achieves New Level of Trade Effluent Monitoring with Analytical Technology Instrumentation. The Royal Mint has selected Analytical Technology to equip its new effluent treatment plant. As a result of the new effluent treatment plant incorporating Analytical Technology instrumentation, The Royal Mint discharge 100 per cent of its trade effluents into the sewer, without damaging the sewer infrastructure or the environment. Key benefits include the instruments being ...
scottpartnership.blogspot.com
The Scott Partnership: Sciformix Executives Drive Agenda on Achieving Drug Safety Excellence as Premium Sponsor of 5th Annual World Drug Safety Congress
http://scottpartnership.blogspot.com/2013/03/sciformix-executives-drive-agenda-on.html
Thursday, 28 March 2013. Sciformix Executives Drive Agenda on Achieving Drug Safety Excellence as Premium Sponsor of 5th Annual World Drug Safety Congress. March 2013 – Sciformix Corporation, a world leading Scientific Process Organization (SPO), has announced its premium s ponsorship of the. 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA . The World Drug Safety Congress aims to present innovative solutions to the key safety cha...
scottpartnership.blogspot.com
The Scott Partnership: Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market
http://scottpartnership.blogspot.com/2013/02/novozymes-biopharmas-ralbumin-approved.html
Thursday, 28 February 2013. Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market. Recombumin Alpha used by MAQUET CARDIOPULMONARY. In a version of the company’s proprietary BIOLINE Coating. NOTTINGHAM, UK – February 27, 2013 –. Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin. Alpha - formerly Albucult. Novozymes’ rAlbumins are...
scottpartnership.blogspot.com
The Scott Partnership: April 2012
http://scottpartnership.blogspot.com/2012_04_01_archive.html
Monday, 2 April 2012. PRECOS Launches Premium Bespoke Collection of Clinically Relevant Lung In Oncology Models for Drug Discovery at AACR Annual Meeting 2012. NOTTINGHAM, UK (2. April 2012) – Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service provider with a specific focus on oncology, today launches its L. Cology model atlas ( LION. At the AACR Annual meeting (Chicago, March 31. 8211; April 4. LION enables the collection of predictive lung models to ...
scottpartnership.blogspot.com
The Scott Partnership: March 2013
http://scottpartnership.blogspot.com/2013_03_01_archive.html
Thursday, 28 March 2013. Sciformix Executives Drive Agenda on Achieving Drug Safety Excellence as Premium Sponsor of 5th Annual World Drug Safety Congress. March 2013 – Sciformix Corporation, a world leading Scientific Process Organization (SPO), has announced its premium s ponsorship of the. 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA . The World Drug Safety Congress aims to present innovative solutions to the key safety cha...
scottpartnership.blogspot.com
The Scott Partnership: December 2012
http://scottpartnership.blogspot.com/2012_12_01_archive.html
Friday, 21 December 2012. Parliamentary Drop-in Event to Support High Quality Ovarian Cancer Services. By Luke Newman, Senior Account Executive (Kapler Communications - Our Sister Company). N May 9 2005, my Mum, Jen Newman took her last breath after a brave 19 month battle against ovarian cancer. She was diagnosed with the ‘Silent Killer’ in October 2003 and went through three different courses of chemotherapy before the disease spread, in the form of cancerous cells, to her stomach. I was also invited t...
scottpartnership.blogspot.com
The Scott Partnership: February 2013
http://scottpartnership.blogspot.com/2013_02_01_archive.html
Thursday, 28 February 2013. Novozymes Biopharma’s rAlbumin approved in Japan as MAQUET expands into new market. Recombumin Alpha used by MAQUET CARDIOPULMONARY. In a version of the company’s proprietary BIOLINE Coating. NOTTINGHAM, UK – February 27, 2013 –. Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin. Alpha - formerly Albucult. Novozymes’ rAlbumins are...
SOCIAL ENGAGEMENT